瑞士
NOVARTIS PHARMA AG
会员限时活动
1580
元/年
企业联系人
详细交易记录
实时最新数据
交易概况
总交易额
8,678,372.87
交易次数
1,191
平均单价
7,286.63
最近交易
2025/04/30
NOVARTIS PHARMA AG 贸易洞察 (采购商)
过去5年,NOVARTIS PHARMA AG在瑞士市场展现出 交易非常活跃,今年已有多笔成交。 总交易额达 8,678,372.87 ,累计 1,191 笔交易。 平均单价 7,286.63 ,最近一次交易于 2025/04/30。
贸易记录
日期 | 交易公司 | 交易描述 | 数量 | 金额 |
---|---|---|---|---|
2013-04-01 | 未公开 | OZONE THERAPY, OXYGEN THERAPY, AEROSOL THERAPY, ARTIFICIAL RESPIRATION OR OTHER THERAPEUTIC RESPIRATION APPARATUS | 未公开 | 未公开 |
2016-03-01 | 未公开 | FOOD PREPARATIONS, N.E.S., CONTAINING, BY WEIGHT, >= 1,5% MILKFAT, >= 5% SUCROSE OR ISOGLUCOSE, >= 5% GLUCOSE OR >= 5% STARCH | 未公开 | 未公开 |
2012-04-01 | 未公开 | MEDICAMENTS CONTAINING ANTIBIOTICS, PUT UP IN MEASURED DOSES INCL. THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. MEDICAMENTS CONTAINING PENICILLINS OR DERIVATIVES THEREOF WITH A PENICILLANIC STRUCTURE, O... | 未公开 | 未公开 |
2017-12-01 | 未公开 | MIXTURES AND PREPARATIONS CONSISTING MAINLY OF 5-ETHYL-2-METHYL-2-OXIDO-1,3,2-DIOXAPHOSPHINAN-5-YL METHYL METHYL METHYLPHOSPHONATE AND BIS[ 5-ETHYL-2-METHYL-2-OXIDO-1,3,2-DIOXAPHOSPHINAN-5-YL METHYL] METHYLPHOSPHONATE | 未公开 | 未公开 |
2013-05-01 | 未公开 | HETEROCYCLIC COMPOUNDS WITH NITROGEN HETERO-ATOMS ONLY, CONTAINING A PYRIMIDINE RING, WHETHER OR NOT HYDROGENATED, OR PIPERAZINE RING IN THE STRUCTURE (EXCL. MALONYLUREA BARBITURIC ACID AND ITS DERIVATIVES, ALLOBARBITAL INN, AMOBARBITAL INN, BARBITAL I... | 未公开 | 未公开 |
2015-07-01 | 未公开 | BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES (EXCL. ANTISERA, HAEMOGLOBIN, BLOOD GLOBULINS AND SERUM GLOBULINS) | 未公开 | 未公开 |
贸易国家分析
HS编码情报
HS编码 | 产品描述 | 频次 |
---|---|---|
854140 | 光电二极管、晶体管、类似半导体器件 | 42 |
847130 | 便携式数字处理设备 | 35 |
851762 | 无线网络接入设备 | 28 |
847330 | 电子计算机零件 | 22 |
852910 | 天线和天线反射器 | 18 |
853400 | 印刷电路板 | 15 |